Ledger.Open graph →
SEC Form D · filed April 9, 2019

Therapix Biosciences Ltd

Offering
$2.2M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
GIVATAYIM, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Adi Zuloff-Shani · Givatayim, L3ExecAmit Berger · Givatayim, L3DirectorEric So · TORONTO, Ontario, CanadaDirectorStephen Simes · Los Angeles, CADirectorAscher Shmulewitz · Givatayim, L3Exec · DirectorOz Adler · Givatayim, L3ExecYafit Stark · Givatayim, L3DirectorZohar Heiblum · Petach-Tikva, L3DirectorStephen Simes · Givatayim, L3DirectorAscher Shmulewitz · Givatayim, L3Exec · DirectorOz Adler · Givatayim, L3ExecAdi Zuloff-Shani · Givatayim, L3ExecAmit Berger · Birmingham, ALDirectorYafit Stark · Givatayim, L3DirectorEric So · TORONTO, Ontario, CanadaDirectorZohar Heiblum · Givatayim, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗